Evidence-based traditional Chinese medicine: present and future_Chinese Journal of Evidence-Based Medicine

Authors：

ZHANG Junhua ¹ , SUN Xin ² ,  LI Youping ² ,  ZHANG Boli ¹

1. Evidence-Based Medicine Centre, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, P.R.China;
2. Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding?author：

LI Youping, Email: yzmylab@hotmail.com; ZHANG Boli, Email: zhangbolipr@163.com

Keywords：

DOI：

10.7507/1672-2531.201904053

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Evidence-based Chinese medicine (EBCM) is one of the innovative achievements in the development of evidence-based medicine (EBM) in China. The EBCM has made initial progress: the evidence-based scientific decision-making model has become popular; a series of key technologies for evidence-based evaluation and research of traditional Chinese medicine (TCM) have been established; several technical specifications have been formulated in line with international standards; clinical evidence database of TCM has been established; a number of high quality clinical trials have been published in internationally renowned journals; and the International Forum on Evidence based Chinese Medicine(EBCM) has become a brand conference. Difficulties in EBCM development mainly involve: lack of high quality clinical evidence, difficulty in producing evidence, and decentralization of research team. Based on opportunities and challenges of the development of TCM, this article proposed the short-term and long-term goals, implementation paths and five key directions for the development of EBCM in the future, and puts forward three suggestions for further development of EBCM.

Citation： ZHANG Junhua, SUN Xin, LI Youping, ZHANG Boli. Evidence-based traditional Chinese medicine: present and future. Chinese Journal of Evidence-Based Medicine, 2019, 19(5): 515-520. doi: 10.7507/1672-2531.201904053 Copy

1.	張伯禮. 面向未來: 世界需要中醫藥. 醫學爭鳴, 2016, 7(1): 1-4.
2.	張俊華, 李幼平, 張伯禮. 循證中醫藥學: 理論與實踐. 中國中藥雜志, 2018, 43(1): 1-7.
3.	國家衛生健康委員會. 《2017年中國衛生事業發展統計公報》. 2018-6-12.
4.	張伯禮, 張俊華, 陳士林, 等. 中藥大健康產業發展機遇與戰略思考. 中國工程科學, 2017, 19(2): 16-20.
5.	中華人民共和國國務院新聞辦公室. 《中國的中醫藥》, 2016年12月.
6.	Cyranoski D. Why Chinese medicine is heading for clinics around the world. Nature, 2018, 561: 448-450.
7.	賴世隆, 胡鏡清, 郭新峰. 循征醫學與中醫藥臨床研究. 廣州中醫藥大學學報, 2000, 17(1): 1-8.
8.	Available at: https://www.nature.com/articles/d41586-018-04886-8.
9.	Ng AWT, Poon SL, Huang MN, et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci Transl Med, 2017, 9(412): pii: eaan6446.
10.	Chan M. WHO Director-General addresses traditional medicine forum. Available at: https://www.who.int/dg/speeches/2015/traditional-medicine/en/.
11.	Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA, 1992, 268(17): 2420-2425.
12.	Medical milestones. https://www.bmj.com/content/medical-milestones.
13.	李幼平, 李靜, 孫鑫, 等. 循證醫學在中國的起源與發展: 獻給中國循證醫學20周年. 中國循證醫學雜志, 2016, 16(1): 2-6.
14.	喻佳潔, 李琰, 陳雯雯, 李幼平. 從循證醫學到循證科學的必然趨勢. 中國循證醫學雜志, 2019, 19(1): 119-124.
15.	第一屆循證中醫藥學國際論壇在天津召開. 中醫雜志, 2016, 57(13): 1165.
16.	張俊華, 孫鑫. 循證中醫藥學. 上海: 上海科技出版社, 2018.
17.	邢冬梅, 張俊華, 張伯禮. 中醫臨床研究核心結局指標集形成路徑. 中華中醫藥雜志, 2014, 29(5): 1352-1355.
18.	張明妍, 張俊華, 杜亮, 等. 核心指標集研制規范(COS-STAD)介紹及其在中醫藥領域應用的思考. 中國循證醫學雜志, 2018, 18(4): 392-396.
19.	邢冬梅. 中醫藥臨床研究藥物依從性測評方法研究. 天津:天津中醫藥大學, 2014.
20.	楊豐文, 田金徽, 張俊華, 等. 中醫藥網狀Meta分析方法及要點. 中醫雜志, 2017, 58(10): 841-844.
21.	劉保延. 真實世界的中醫臨床科研范式. 中醫雜志, 2013, 54(6): 451-455.
22.	張俊華, 任經天, 胡鏡清, 等. 中藥注射劑臨床安全性集中監測研究設計與實施專家共識. 中國中藥雜志, 2017, 42(1): 6-9.
23.	陳吉, 孫月, 布優祥, 等. 中醫領域真實世界研究現狀分析. 中國循證醫學雜志, 2018, 18(11): 1216-1223.
24.	張冬, 張俊華, 鄭文科, 等. 中藥臨床安全性研究注冊平臺(CSRP)的構建. 世界科學技術-中醫藥現代化, 2016, 18(12): 2097-2100.
25.	MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med, 2010, 7(6): e1000261.
26.	Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration. Ann Intern Med, 2017, 167(2): 112-121.
27.	中醫藥臨床證據數據庫. Available at: http://tcmevd.com/evidence/index.
28.	中藥注射劑臨床有效性證據指數發布. Available at: http://www.xinhuanet.com/health/2018-10/15/c_1123560857.htm.
29.	Shang H, Zhang J, Yao C, et al. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med, 2013, 2013: 738391.
30.	Li X, Zhang J, Huang J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol, 2013, 62(12): 1065-1072.
31.	Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med, 2011, 155(4): 217-225.
32.	Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med, 2016, 165(11): 761-769.
33.	Liu Z, Liu Y, Xu H, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA, 2017, 317(24): 2493-2501.
34.	李慧, 陳耀龍, 杜亮, 等. 促進循證中醫藥指南制定的策略與建議: 廣州宣言. 中國循證醫學雜志, 2016, 16(7): 745-748.
35.	蔣躍絨, 陳可冀. 關于中醫藥循證臨床實踐指南的制定和質量評價. 中國中西醫結合雜志, 2016, 36(1): 11-15.
36.	中國循證醫學發展邁向新時代. Available at: http://health.gmw.cn/2018-10/13/content_31684389.htm.
37.	張明妍, 楊豐文, 李越, 等. 《中國中西醫結合雜志》刊載中醫藥隨機對照試驗報告質量的研究. 中國循證醫學雜志, 2017, 17(3): 357-363.
38.	國家中醫藥管理局. Available at: http://bgs.satcm.gov.cn/gongzuodongtai/2019-03-15/9319.html.
39.	張俊華, 孫鑫, 杜亮, 等. " 新時代循證醫學發展”天津宣言. 中國循證醫學雜志, 2018, 18(10): 1017.

1. 張伯禮. 面向未來: 世界需要中醫藥. 醫學爭鳴, 2016, 7(1): 1-4.
2. 張俊華, 李幼平, 張伯禮. 循證中醫藥學: 理論與實踐. 中國中藥雜志, 2018, 43(1): 1-7.
3. 國家衛生健康委員會. 《2017年中國衛生事業發展統計公報》. 2018-6-12.
4. 張伯禮, 張俊華, 陳士林, 等. 中藥大健康產業發展機遇與戰略思考. 中國工程科學, 2017, 19(2): 16-20.
5. 中華人民共和國國務院新聞辦公室. 《中國的中醫藥》, 2016年12月.
6. Cyranoski D. Why Chinese medicine is heading for clinics around the world. Nature, 2018, 561: 448-450.
7. 賴世隆, 胡鏡清, 郭新峰. 循征醫學與中醫藥臨床研究. 廣州中醫藥大學學報, 2000, 17(1): 1-8.
8. Available at: https://www.nature.com/articles/d41586-018-04886-8.
9. Ng AWT, Poon SL, Huang MN, et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci Transl Med, 2017, 9(412): pii: eaan6446.
10. Chan M. WHO Director-General addresses traditional medicine forum. Available at: https://www.who.int/dg/speeches/2015/traditional-medicine/en/.
11. Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA, 1992, 268(17): 2420-2425.
12. Medical milestones. https://www.bmj.com/content/medical-milestones.
13. 李幼平, 李靜, 孫鑫, 等. 循證醫學在中國的起源與發展: 獻給中國循證醫學20周年. 中國循證醫學雜志, 2016, 16(1): 2-6.
14. 喻佳潔, 李琰, 陳雯雯, 李幼平. 從循證醫學到循證科學的必然趨勢. 中國循證醫學雜志, 2019, 19(1): 119-124.
15. 第一屆循證中醫藥學國際論壇在天津召開. 中醫雜志, 2016, 57(13): 1165.
16. 張俊華, 孫鑫. 循證中醫藥學. 上海: 上海科技出版社, 2018.
17. 邢冬梅, 張俊華, 張伯禮. 中醫臨床研究核心結局指標集形成路徑. 中華中醫藥雜志, 2014, 29(5): 1352-1355.
18. 張明妍, 張俊華, 杜亮, 等. 核心指標集研制規范(COS-STAD)介紹及其在中醫藥領域應用的思考. 中國循證醫學雜志, 2018, 18(4): 392-396.
19. 邢冬梅. 中醫藥臨床研究藥物依從性測評方法研究. 天津:天津中醫藥大學, 2014.
20. 楊豐文, 田金徽, 張俊華, 等. 中醫藥網狀Meta分析方法及要點. 中醫雜志, 2017, 58(10): 841-844.
21. 劉保延. 真實世界的中醫臨床科研范式. 中醫雜志, 2013, 54(6): 451-455.
22. 張俊華, 任經天, 胡鏡清, 等. 中藥注射劑臨床安全性集中監測研究設計與實施專家共識. 中國中藥雜志, 2017, 42(1): 6-9.
23. 陳吉, 孫月, 布優祥, 等. 中醫領域真實世界研究現狀分析. 中國循證醫學雜志, 2018, 18(11): 1216-1223.
24. 張冬, 張俊華, 鄭文科, 等. 中藥臨床安全性研究注冊平臺(CSRP)的構建. 世界科學技術-中醫藥現代化, 2016, 18(12): 2097-2100.
25. MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med, 2010, 7(6): e1000261.
26. Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration. Ann Intern Med, 2017, 167(2): 112-121.
27. 中醫藥臨床證據數據庫. Available at: http://tcmevd.com/evidence/index.
28. 中藥注射劑臨床有效性證據指數發布. Available at: http://www.xinhuanet.com/health/2018-10/15/c_1123560857.htm.
29. Shang H, Zhang J, Yao C, et al. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med, 2013, 2013: 738391.
30. Li X, Zhang J, Huang J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol, 2013, 62(12): 1065-1072.
31. Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med, 2011, 155(4): 217-225.
32. Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med, 2016, 165(11): 761-769.
33. Liu Z, Liu Y, Xu H, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA, 2017, 317(24): 2493-2501.
34. 李慧, 陳耀龍, 杜亮, 等. 促進循證中醫藥指南制定的策略與建議: 廣州宣言. 中國循證醫學雜志, 2016, 16(7): 745-748.
35. 蔣躍絨, 陳可冀. 關于中醫藥循證臨床實踐指南的制定和質量評價. 中國中西醫結合雜志, 2016, 36(1): 11-15.
36. 中國循證醫學發展邁向新時代. Available at: http://health.gmw.cn/2018-10/13/content_31684389.htm.
37. 張明妍, 楊豐文, 李越, 等. 《中國中西醫結合雜志》刊載中醫藥隨機對照試驗報告質量的研究. 中國循證醫學雜志, 2017, 17(3): 357-363.
38. 國家中醫藥管理局. Available at: http://bgs.satcm.gov.cn/gongzuodongtai/2019-03-15/9319.html.
39. 張俊華, 孫鑫, 杜亮, 等. " 新時代循證醫學發展”天津宣言. 中國循證醫學雜志, 2018, 18(10): 1017.

Previous Article
From evidence-based medicine to evidence-based science: the connotation and thinking
Next Article
Using real-world evidence for drug and medical device evaluation and regulatory decisions

Chinese Journal of Evidence-Based Medicine

Evidence-based traditional Chinese medicine: present and future

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content